(4147) Announcements Received US FDA If the TMB-355 is listed after the listing of the contents of the label and the contents of the product, the company is satisfied with the content, the current BLA review and supplement are scheduled as the original The progress is in progress. (Editorial: Zhang Jiayi)
Chinese press release:
https://ww2.money-link.com.tw/RealtimeNews/NewsContent.aspx?SN=3257668001&PU=0010